Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Methods × 30 days × Clear all

Sponsor

Conditions

Skin Carcinoma 2 Pain 2 Neoplasms 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Tobacco Smoking 1 Smoking Cessation 1 Smoking 1 Sepsis 1 Papillomavirus Infections 1 Neoplasm Metastasis 1 Lymphoma 1 Inflammatory Breast Neoplasms 1 Hematologic Neoplasms 1 Frailty 1 Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1 Cigarette Smoking 1 Chemotherapy-Induced Peripheral Neuropathy 1 Behavior, Addictive 1 Alzheimer Disease 1 Agnosia 1

Interventions

Nivolumab 19 cabozantinib 14 Magnetic Resonance Spectroscopy 14 pembrolizumab 12 Specimen Handling 12 Ipilimumab 12 lenvatinib 5 Biopsy 5 atezolizumab 4 Immunoglobulin G 4 Everolimus 4 CTLA-4 Antigen 4 Axitinib 4 pazopanib 3 cemiplimab 3 Disulfides 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 tivozanib 2 spartalizumab 2 belzutifan 2 avelumab 2 aldesleukin 2 aflibercept 2 Watchful Waiting 2 Pluvicto 2 Nephrectomy 2 IFL protocol 2 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡